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imputing	SNP	genotypes	into	10	CEU	samples. These results are based on using 
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Online	methods	
	
Union	site	list		
Every	study	provided	us	with	their	most	recent	version	of	their	haplotypes	in	
VCF	format	with	one	VCF	for	every	autosome.	For	every	cohort,	bcftools	(v0.2.0-
rc12)	was	used	to	create	an	entire-autosome,	SNP-only	site	list	with	alternate	
and	total	allele	count	information	from	these	per-chromosome	haplotypes.	
Multiallelic	SNPs	were	broken	into	biallelics	using	‘bcftools	norm’.	These	per-
cohort	site	lists	were	merged	into	a	single	file	using	an	in-house	Perl	script	that	
correctly	merges	alternate	and	total	allele	counts.	We	created	site	lists	called	
MAC2	and	MAC5	containing	only	sites	with	a	minor	allele	count	(MAC)	across	all	
studies	of	>=	2	and	>=5,	respectively,	using	bcftools.	These	sites	lists	contained	
95,855,206	and	51,060,347	sites,	respectively.	
	
Genotype	likelihood	calculations	
The	'samtools	mpileup'	command	was	used	to	generate	genotype	likelihoods	
(GLs)	at	all	MAC2	sites	on	a	per	sample	basis	from	each	sample’s	BAM	file.	The	
pipeline	and	software	versions	have	been	made	available	online	(see	URLs).	The	
resulting	BCF	files	were	merged	using	the	'bcftools	merge'	command	and	the	
MAC2	sites	and	alleles	extracted	using	the	'bcftools	call'	command.	The	use	of	
'bcftools	call'	here	made	a	baseline	set	of	non-LD	based	genotype	calls	for	each	
site	across	all	samples.	These	calls	were	used	for	some	initial	sample	QC	(see	
Sample	filtering	section).	We	calculated	GLs	on	33,070	samples	in	total.	
	
Site	filtering	
We	used	an	ad-hoc	method	for	initial	variant	filtering	which	enabled	us	to	
identify	variants	that	had	been	filtered	out	‘quite	often’	by	our	submitting	
studies.	For	each	site	and	for	each	cohort,	we	labelled	the	site	as	“called”	in	that	
study	if	the	putative	calls	from	bcftools	based	on	GLs	exhibited	more	than	one	
allele	in	that	cohort,	or	“not	called”	if	it	showed	no	variation.	We	also	used	the	
haplotype	sets	provided	by	each	study	to	determine	whether	each	study	had	
filtered	out	each	site	or	not	using	their	own	internal	calling	pipeline.	To	
determine	a	threshold	of	“number	of	times	filtered	out”,	we	stratified	the	sites		
according	to	their	called	status	versus	their	filtered	status	(Supplementary	
Figure	5).	We	also	measured	the	Ts/Tv	ratio	of	the	set	of	SNPs	for	each	of	these	
stratified	combinations.	SNPs	corresponding	to	the	cells	above	the	red	line	in	the	
figure	were	filtered	out,	removing	all	cells	which	had	been	filtered	out	by	more	
than	4	studies	or	have	Ts/Tv	ratio	less	than	1.7. 	
	
We	also	applied	a	set	of	additional	site	filters	as	follows.	We	filtered	out	sites	not	
on	the	MAC5	site	list	to	restrict	the	site	list	to	those	that	could	be	imputed	well.	
We	also	filtered	out	sites	if	(i)	any	study	(apart	from	1000	Genomes)	had	a	
Hardy-Weinberg	Equilibrium	(HWE)	p-value	<	10-10,	(ii)	any	study	(apart	from	
1000	Genomes)	had	an	overall	inbreeding	coefficient	<	-0.1,	(iii)	a	MAF>0.1	with	
the	site	being	called	in	fewer	than	3	of	the	studies	and	not	called	in	1000	
Genomes	(the	latter	restriction	kept	sites	present	at	high	frequencies	in	non-
European	populations	that	were	only	called	in	1000	Genomes).		We	also	filtered	
out	sites	called	only	in	the	GoNLstudy	or	IBD	cohort.	We	completely	excluded	
GPC	haplotypes	from	this	step	of	the	site	list	creation	process.		
	
After	applying	these	filters,	the	site	list	comprised	of	44,038,997	sites.	Finally,	we	
made	sure	that	4,914,335	sites	found	on	a	selection	of	common	SNP	genotyping	
arrays	and	those	used	in	the	GIANT	consortium	and	the	Global	Lipids	
Consortium	(Supplementary	Table	7)	were	included	in	the	final	site	list.		The	
final	site	list	after	this	filtering	contained	44,187,567	sites.	
	
Sample	filtering	
Having	used	'bcftools	call'	to	extract	sites	and	alleles,	we	had	a	set	of	baseline	
non-LD	genotype	calls	(see	Genotype	likelihood	calculations	section).	Based	on	
these	calls	for	chromosome	22,	some	outlier	samples	were	evident	and	we	
removed	150	samples	showing	evidence	for	fewer	than	10,000	non-reference	
SNPs	or	more	than	10	singletons	across	the	chromosome.	This	left	a	total	of	
32,920	samples.	
	
To	detect	possible	duplicates	we	used	the	original	genotype	calls	submitted	by	
the	individual	studies.	We	selected	1000	random	sites	that	(1)	were	biallelic;	(2)	
had	European	minor	allele	frequency	>	5%	in	1000GP3;	and	(3)	had	no	missing	
data	in	any	of	the	individual	studies.	Using	the	'bcftools	gtcheck'	command,	we	
counted	the	number	of	genotypes	that	differed	between	each	sample	pair.	There	
was	a	clear	set	of	269	sample	pairs	with	very	few	genotypes	differing	over	the	
1000	sites.	We	identified	these	samples	as	duplicates	either	within	or	between	
studies	and	removed	one	of	the	samples	in	the	pair	as	described	in	
Supplementary	Table	8.	Due	to	some	samples	being	represented	more	than	
twice,	there	were	a	total	of	261	samples	removed	due	to	duplicates.	Before	
genotype	calling,	we	also	removed	(i)	9	samples	for	which	we	had	Complete	
Genomics	data	so	that	we	could	use	these	samples	for	testing	purposes,	(ii)	31	
samples	from	1000GP3	that	were	related	samples	(see	URLs),	(iii)	8	samples	
from	the	HELIC,	AMD	and	ProjectMinE	studies	with	sample	labeling	
inconsistencies.	These	filters	resulted	in	32,611	samples	being	used	for	the	
genotype	calling	and	phasing	steps.	
	
In	addition,	after	the	phasing,	83	samples	from	the	AMD	study	were	removed	as	
the	consent	for	these	samples	had	been	removed.		We	also	repeated	the	
duplicate	detection	process	on	the	final	HRC	genotype	calls,	since	some	studies	
increased	in	size	late	on	within	the	analysis	process.	This	resulted	in	an	extra	40	
samples	being	removed	and	a	total	of	32,488	samples	in	the	final	phased	
reference	panel.	
	
Genotype	calling	method	leveraging	existing	haplotype	calls	
We	called	genotypes	from	the	genotype	likelihoods	computed	on	the	HRC	
samples	by	extending	the	SNPTools22	algorithm	to	leverage	pre-existing	
haplotypes	available	from	each	cohort.	Like	other	phasing	and	calling	
approaches8,10,	SNPTools	is	an	MCMC	approach	in	which	each	sample's	
haplotypes	and	genotypes	are	iteratively	updated	using	the	current	estimates	of	
all	other	samples.	A	low-complexity	Hidden	Markov	Model	(HMM)	with	just	four	
states	is	used	to	update	each	sample,	where	the	states	are	a	set	of	four	"surrogate	
parent"	haplotypes.	The	MCMC	sampler	employs	a	Metropolis-Hastings	(MH)	
step	to	sample	the	set	of	surrogate	parents.	In	large	sample	sizes	the	search	
space	for	these	surrogate	haplotypes	is	huge	and	results	in	low	acceptance	rates	
for	the	sampler.	Our	extension,	called	GLPhase	(see	URLs)	uses	pre-existing	
haplotypes	to	restrict	the	set	of	possible	haplotypes	from	which	the	MH	sampler	
may	choose	surrogate	parent	haplotypes.	For	each	individual,	we	restrict	the	
search	space	to	200	haplotypes	that	most	closely	match	the	two	pre-existing	
haplotypes	of	the	individual	using	a	Hamming	distance	metric	(100	for	each	
haplotype).	We	run	the	method	on	chunks	of	1,024	sites	at	a	time,	which	is	the	
default	setting	for	SNPtools.	Since	the	pre-existing	haplotypes	from	each	study	
do	not	contain	exactly	the	same	set	of	sites	we	filled	in	missing	alleles	in	the	pre-
existing	haplotypes	at	our	site	list	using	the	major	allele	at	each	site.	
	
Restricting	the	search	space	in	this	way	allows	us	to	reduce	the	number	of	burn-
in	iterations	from	56	to	5,	the	number	of	sampling	iterations	from	200	to	95,	and	
the	number	of	MH	steps	taken	at	each	iteration	for	each	individual	from	2N	to	
100,	where	N	is	the	number	of	samples	being	phased.	This	reduces	the	
complexity	of	our	phasing	algorithm	from	O(N2)	to	O(N).	Although	our	
implementation	of	the	Hamming	distance	search	has	complexity	O(N2),	for	N	=	
30,000,	the	impact	of	the	search	on	run	time	is	small	(~5%	of	run	time	on	each	
chunk).	A	chunk	of	1024	sites	can	be	phased	in	~200	minutes	using	~1.3GB	of	
RAM.	Once	sample	sizes	are	encountered	where	the	Hamming	distance	search	
begins	to	dominate,	our	implementation	could	be	replaced	with	O(N	log	N)	
clustering	algorithms	that	we	have	implemented	within	the	SHAPEIT3	
algorithm12.		
	
To	illustrate	how	important	GLPhase	was	to	genotype	calling	and	phasing	on	
such	a	large	sample	size,	we	carried	out	a	comparison	to	Beagle	3.1,	Beagle	4.1	
and	the	original	SNPTools	method.	We	ran	all	four	methods	on	five	randomly	
selected	1024	site	chunks	from	chromosome	20	on	the	cluster	using	increasing	
sample	sizes	and	measured	run	time.	Supplementary	Figure	6	shows	that	
GLPhase	is	approximately	100	times	faster	than	the	next	quickest	method	at	the	
full	HRC	sample	size.	
	
Final	phasing	and	haplotype	estimation	
We	estimated	haplotypes	from	GLPhase	genotype	calls	using	SHAPEIT312.	
Chromosomes	were	phased	in	chunks	consisting	of	16,000	variants	plus	3,300	
variants	overlapping	with	neighboring	chunks	on	either	side.		The	non-default	
command	line	option	-w	0.5	was	used	for	SHAPEIT3.		Chunks	were	ligated	using	
the	ligateHAPLOTYPES	program	(see	URLs).	SHAPEIT3	does	not	handle	multiple	
variants	at	the	same	genomic	coordinate,	so	multiallelic	sites	(SNPs	with	3	or	4	
alleles)	were	shifted	by	one	or	two	base	pairs	for	rephasing,	and	then	moved	
back	to	their	original	position	after	chunk	ligation.	
	
Evaluation	of	genotype	calling	process	
We	tested	the	genotype	calling	process	on	data	from	chromosome	20	with	
different	combinations	of	site	lists	and	sample	sets	to	assess	both	the	effects	of	
site	filtering	and	the	benefits	of	increasing	samples	size.	We	evaluated	3	different	
site	lists:	the	1000	Genomes	Phase	3	set	of	sites	(775,927),	our	HRC	MAC5	site	
list	(1,128,114)	and	our	HRC	MAC5	site	list	with	additional	site	filtering	
(1,006,559).	We	ran	the	genotype	calling	method	on	3	different	sets	of	samples	:	
the	2,525	original	1000	Genomes	Phase	3	samples,	a	subset	of	13,309	HRC	
samples	that	we	used	at	an	early	stage	of	HRC	testing	(HRC	Pilot)	from	studies	
1000GP3,	AMD,	GoNL,	GoT2D,	ORCADES,	SardinIA,	FINLAND	and	UK10K,	and	the	
near-final	full	set	of	32,905	HRC	samples.	We	called	genotypes	using	GLPhase	on	
each	of	these	9	datasets	and	examined	genotype	discordance	compared	to	
Illumina	OMNI2.5M	genotypes	produced	by	the	1000	Genomes	Project.	For	this	
comparison,	we	focused	only	on	genotypes	from	365	samples	shared	across	the	
3	sample	sets	and	at	42,244	SNP	sites.	We	calculated	percentage	discordance	for	
the	3	possible	genotypes	consisting	of	reference	(REF)	and	alternate	(ALT)	
alleles	as	well	as	an	overall	non-reference	allele	discordance	rate	(NRD).	Results	
are	shown	in	Supplementary	Table	2.	
	
Downstream	imputation	performance	
We	assessed	imputation	accuracy	of	4	different	reference	panels	:	1000	Genomes	
Phase	3,	UK10K,	and	two	versions	of	the	HRC	reference	panel,	with	and	without	
re-phasing	with	SHAPEIT3.	To	do	this	we	used	high-coverage	WGS	data	made	
publicly	available	by	Complete	Genomics	(CG)	(see	URLs).	For	the	pseudo-GWAS	
samples	we	used	data	from	10	CEU	samples	that	also	occur	in	the	1000	Genomes	
Phase	3	samples.	These	samples	were	removed	from	the	various	reference	
panels	before	using	them	to	assess	imputation	performance.		
Three	pseudo-GWAS	panels	were	created	based	on	three	chip	lists	(see	URLs)	:	
The	Illumina	Omni	5M	SNP	array	(HumanOmni5-4v1-1_A),	the	Illumina	Omni	1M	
SNP	array	(Human1M-Duo	v3C),	and	the	Illumina	Core	Exome	SNP	array	
(humancoreexome-12v1-1_a).	For	these	comparisons	we	only	used	sites	in	the	
intersection	of	the	reference	panels	to	enable	a	direct	comparison.	
These	pseudo-chip	genotypes	were	used	to	impute	the	remaining	genotypes	
which	were	then	compared	to	the	held	out	genotypes,	stratifying	results	by	MAF	
of	the	imputed	sites.	
Imputation	was	carried	out	using	IMPUTE27	which	chooses	a	custom	reference	
panel	for	each	study	individual	in	each	2	Mb	segment	of	the	genome.	We	set	the	
khap	parameter	of	IMPUTE2	to	1000.	All	other	parameters	were	set	to	default	
values.	We	stratified	imputed	variants	into	allele	frequency	bins	and	calculated	
the	squared	correlation	between	the	imputed	allele	dosages	at	variants	in	each	
bin	with	the	masked	CG	genotypes	(called	aggregate	r2	in	Figure	1).	Non-
reference	allele	frequency	for	each	SNP	was	calculated	from	HRC	release	1	GLs	at	
MAC>=5	sites.	Figure	1	shows	the	results	for	the	Illumina	Omni	1M	chip.	
Supplementary	Figures	3	and	4	show	the	results	from	the	Illumina	Core	Exome	
chip	and	the	Illumina	Omni	5M	chip	respectively.	
Details	of	imputation,	association	testing	and	replication	in	the	InCHIANTI	study	
A	total	of	1,210	individuals	from	the	InCHIANTI	study	were	genotyped	using	the	
Illumina	Infinium	HumanHap550	genotyping	array13,14	.	Individuals	were	pre-
phased	using	autosomal	SNPs	after	filtering	out	SNPs	with	MAF	<1%,	Hardy-
Weinberg	p-value	<10-04,	and	missingness	>1%.	SNPs	were	also	removed	if	they	
could	not	be	remapped	to	the	GRCh37	(hg19)	human	reference.	This	resulted	in	
483,991	SNPs	available	for	pre-phasing.	Phasing	was	performed	locally	using	
SHAPEIT2	10. 	
	
Imputation	was	performed	remotely	using	the	Michigan	Imputation	Server	(see	
URLs).	A	total	of	39,235,157	SNPs	and	47,045,346	variants	were	imputed	from	
the	HRC	and	1000	Genomes	Phase	3	(v5)	reference	panels,	respectively.	An	
imputation	quality	threshold	of	r2	>0.5	was	subsequently	applied	to	both	
imputation	datasets	prior	to	association	testing.	This	resulted	in	15,501,516	and	
13,589,949	variants	available	for	association	analysis	derived	from	HRC-	and	
1000	Genomes-based	imputation,	respectively.	
	
A	total	of	93	circulating	factors	available	in	the	InCHIANTI	study	were	double	
inverse-normalised,	while	adjusted	for	age	and	sex,	prior	to	association	testing	
14,15.	Association	analysis	was	performed	using	a	linear	mixed	model	framework	
as	implemented	in	GEMMA	(see	URLs).	Plots	of	association	in	Figure	2	were	
produced	using	LocusZoom	(see	URLs).	
	
We	attempted	to	replicate	the	associations	reported	in	Supplementary	Table	3	in	
the	SHIP	and	SHIP-TREND	cohorts23.	The	SHIP	samples	were	genotyped	using	
the	Affymetrix	Genome-Wide	Human	SNP	Array	6.0.	The	SHIP-TREND	samples	
was	genotyped	using	the	Illumina	Human	Omni	2.5	array.	Prior	to	imputation,	
duplicate	samples	(by	IBS),	samples	with	reported	vs.	genotyped	gender	
mismatch	or	samples	with	a	very	high	heterozygosity	rate	were	excluded.	
Additionally,	all	monomorphic	SNPs,	SNPs	with	duplicate	chromosomal	position,	
SNPs	with	pHWE	<0.0001	and	SNPs	with	a	callrate	<95%	were	filtered.	
Imputation	was	performed	on	the	Sanger	Imputation	Service	(see	URLs)	against	
the	HRC	panel.	In	total,	4,070	SHIP	samples	and	986	SHIP-TREND	samples	were	
included	in	the	imputation	of	genotypes.	Association	analyses	were	conducted	
using	SNPTEST	v2.5.224.	
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